Treatment and Clinical Management of Chronic Thromboembolic Pulmonary Hypertension:An Update of Literature Review

作     者：Yuan Ren Yingxian Sun Zhiguang Yang Yanli Chen 

作者机构：The Department of CardiologyThe First Affiliated Hospital of China Medical UniversityShenyang110000China The Radiology DepartmentShengjing Hospital of China Medical UniversityShenyang110020China 

出 版 物：《Congenital Heart Disease》 (先天性心脏病（英文）)

年 卷 期：2024年第19卷第2期

页      面：157-176页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Chronic thromboembolic pulmonary hypertension(CTEPH) chronic thromboembolic pulmonary disease(CTEPD) pulmonary endarterectomy(PEA) balloon pulmonary angioplasty(BPA) COVID-19 

摘      要：Chronic thromboembolic pulmonary hypertension(CTEPH)is a chronic,progressive,debilitating,and life-threa-tening complication of pulmonary embolism(PE).Recent technological advances have permitted various treat-ment options for the treatment of CTEPH,including surgery,angioplasty,and medical treatment,depending on the location and characteristics of *** endarterectomy(PEA)is the treatment of choice for CTEPH,as it offers excellent long-term outcomes and a high probability of ***,various medical and interventional therapies are currently being developed for patients with inoperable *** review mainly summarizes the current treatment approaches of CTEPH,offering more options for specialist physicians to,thus,better manage chronic thromboembolic syndromes.